Ionis Pharmaceuticals, Inc.
Selective Antisense Compounds and Uses Thereof

Last updated:

Abstract:

The present invention provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.

Status:
Application
Type:

Utility

Filling date:

3 Sep 2020

Issue date:

5 Aug 2021